、

Zhang Dan

Foreign Member of the Russian Academy of Engineering

Foreign Member of the Russian Academy of Engineering, Co-founder and Chief Strategy Officer of ClinChoice Medical, Director of the China Pharmaceutical Innovation and Research Development Association (PhIRDA), and Vice Chair of the Innovation R&D Service Professional Committee. He previously oversaw clinical development in the North American market for Italy’s SIGMA-TAU. Prior to that, Zhang Dan pioneered the Greater China market for Quintiles Transnational Corp. (now IQVIA), serving as its first Chairman for Greater China. From 1995 to 2000, he held the position of Vice President and member of the Executive Committee at the company’s global headquarters.